How to verify high-purity claims for technical-grade fungicides

A high purity fungicide technical should come with evidence that connects its stated active ingredient content to a specific batch, a suitable analytical method, and controlled impurity limits. A certificate of analysis showing a high assay value is only one part of that evidence. It does not establish that the material has the correct identity, meets relevant impurity requirements, or will behave consistently during formulation.

The most useful purchasing question is therefore: Does this batch meet a complete, applicable specification, and can the supplier demonstrate how the results were obtained? Answering that requires checking the measurement basis, manufacturing source, sampling, and analytical reliability alongside the headline purity figure.

Define what the purity claim actually measures

“High purity” is a descriptive claim, not a universal technical grade. Its meaning depends on the active substance, manufacturing process, intended formulation, and applicable regulatory specification. Technical material generally contains the active ingredient together with manufacturing impurities; a technical concentrate may also contain deliberately added components. Establish which material type is being supplied before comparing percentages.

Start by confirming the active substance’s chemical identity, including its chemical form and any relevant stereochemical composition. A familiar common name or matching CAS number is useful, but it may not resolve every distinction involving salts, isomers, or mixtures. Where those distinctions affect the registered identity or performance, they belong in the specification.

Next, establish how the assay is expressed. An as-received result includes moisture and other components present in the sample. A dry-basis result mathematically excludes the measured moisture contribution. Results calculated on different bases cannot be compared directly. A supplier reporting a dry-basis assay should also provide the moisture result and calculation basis so the delivered material’s active content can be understood.

Also distinguish chromatographic area percentage from active ingredient mass fraction. A dominant peak does not automatically mean the same percentage by weight. Different substances can produce different detector responses, while water, inorganic salts, or other components may be invisible to the selected method. A quantitative assay needs suitable calibration and a defined calculation.

Turn the certificate of analysis into a traceable record

A useful certificate of analysis, or CoA, identifies the batch and reports actual results against agreed acceptance limits. A generic specification sheet describes what a supplier offers; it does not show what a particular batch contains.

Check that the certificate includes:

• The manufacturer, manufacturing site or a traceable site reference, product identity, and batch number.
• Manufacturing and testing dates, with an applicable retest or expiry date where assigned.
• Numerical results, units, acceptance limits, and the reporting basis for the active ingredient assay.
• Results for specified impurities and other controlled properties, with analytical method references.
• An identifiable approval record and document version.

Match the batch number to the container labels and shipment records. If a distributor issues the certificate, the documentation should preserve the link to the original manufacturer and batch. Repacking or blending requires additional traceability because the delivered lot may no longer correspond directly to one original production batch.

Statements such as “complies” can be appropriate for some qualitative checks, but they provide limited visibility for critical quantitative properties. Actual values help reveal whether results are stable, drifting toward a limit, or unusually repetitive across batches.

Check whether the analytical method supports the claim

HPLC and GC are common tools for pesticide analysis, but naming an instrument does not establish method suitability. The method must distinguish the active ingredient from impurities and degradation products, measure it reliably in the technical material, and produce results precise enough for the specification.

Request a method reference and a validation summary appropriate to its use. An established published method can be a strong starting point, although the laboratory still needs to demonstrate that it performs adequately with its equipment and the material being tested. A method developed for a formulated product may require different preparation or validation before use on technical material.

Look for separation, calibration, and reliable sample preparation

Selectivity is particularly important when a supplier changes its synthesis route. An impurity from the new process could overlap with the active ingredient peak and inflate the assay. A chromatogram showing a clean-looking main peak is helpful, but additional evidence may be needed to establish that the peak contains only the intended analyte.

Calibration should use an appropriate reference standard with documented identity, assigned purity, and suitable storage and validity controls. The calculation must account for the standard’s assigned content. Otherwise, a systematic calibration error can make repeated results appear consistent while remaining inaccurate.

Sample preparation deserves equal attention. Incomplete dissolution, analyte degradation during extraction, or losses during filtration can distort the result. Relevant validation evidence normally addresses accuracy or recovery, precision, the working range, and robustness. For impurity methods, the quantification limit must be low enough to assess the specified acceptance limit reliably.

When a result sits close to a contractual limit, apply a predefined decision rule that addresses measurement uncertainty. Rounding conventions should also be agreed in advance. A displayed result at the limit may conceal an unrounded value that changes the acceptance decision.

Assess impurities separately from the active ingredient assay

A higher assay does not necessarily mean a safer or more suitable material. A small amount of a particular toxicologically significant impurity can matter more than a larger amount of a less concerning by-product. Two batches with similar active ingredient content can therefore have different acceptance outcomes.

Build the impurity review around the active substance and its production route. Potential concerns include reaction by-products, unreacted starting materials, residual solvents, catalysts, and degradation products. The relevant set varies by chemistry; a generic screening panel cannot replace a substance-specific assessment.

Give particular attention to relevant impurities: impurities identified as significant because of their toxicological, environmental, or other adverse effects. Where these have specified limits, they need suitable analytical control independently of the main assay. A high active ingredient result does not compensate for exceeding an impurity limit.

Interpret “not detected” carefully. It means the method did not detect the substance above its detection capability under the test conditions. It does not mean zero. For a limit-based acceptance decision, the report should make clear whether the method can quantify the impurity sufficiently below the applicable limit.

Unknown chromatographic peaks also need context. Their significance depends on their response, likely identity, consistency, and relationship to the established impurity profile. Simply subtracting the active ingredient assay from the total cannot identify the remaining material or demonstrate that it is acceptable.

Use the right specification for the source and destination

The purchasing specification should reflect the requirements applicable to the active substance, manufacturing source, and intended destination. An internationally recognized pesticide specification, where available and applicable, can provide a useful technical reference. Its scope and source applicability still matter.

For regulated pesticide supply chains, a material’s acceptability can depend on the approved technical source and impurity profile. A supplier cannot establish equivalence to an accepted source solely by matching the active ingredient assay. Differences in manufacturing route or impurity composition may require a separate assessment under the relevant authorization framework.

Keep supplier qualification and batch release connected but distinct. Qualification establishes whether the manufacturer can consistently supply acceptable material. Batch release establishes whether the delivered lot meets the agreed criteria. Strong historical performance supports a proportionate testing program, but it does not make manufacturing changes irrelevant.

A quality agreement should require notification of changes that could affect identity, assay, or impurities. These include changes to synthesis route, manufacturing location, significant raw material sources, purification, and analytical methods. Such changes can alter the evidence needed to support continued acceptance.

Make the sample representative of the shipment

Even a highly accurate laboratory result applies directly only to the sample tested. If the supplier sends a specially selected sample, its result may not represent the commercial shipment. Verification therefore begins with an agreed sampling plan and documented sample handling.

The plan should consider lot size, packaging, physical form, and the likelihood of variation within the batch. Powders can segregate, moisture can vary between containers, and material may change during transport. These conditions affect where and how increments should be taken.

Composite samples are useful for estimating average composition, but they can dilute a localized problem. Where container-to-container variation or contamination is a concern, retain individual samples or test selected containers separately. Avoid using an average result to dismiss a failure in an individual container when container-level conformity matters.

Record sample identity, collection locations, dates, seals, storage conditions, and transfers between parties. Keep sealed retention samples under suitable conditions for the agreed retention period. Sampling procedures should also address exposure controls and contamination prevention using the material’s hazard information.

Choose independent testing that resolves a specific uncertainty

Independent analysis is especially useful for a new supplier, a changed production source, unexplained batch variation, questionable documentation, or a disagreement near an acceptance limit. Its value comes from testing the uncertainty that matters. Repeating only the main assay may leave the principal impurity concern unanswered.

Select a laboratory with demonstrated capability for the active substance, matrix, and required impurity measurements. Accreditation to ISO/IEC 17025 can support confidence, but inspect the relevant scope: accreditation for unrelated testing does not establish competence for the required pesticide analysis.

Agree on the test methods, reference standards, reporting basis, detection and quantification limits, and acceptance rules before dispatching samples. Where possible, compare supplier and independent results using portions of the same representative sample. Otherwise, a disagreement may reflect sampling variation as well as laboratory differences.

If results conflict, investigate sample preparation, calibration, moisture correction, peak identification, and calculation details. Do not repeatedly retest until a passing result appears. An unexplained discrepancy is itself a reason to hold the batch while its cause is assessed.

Release the batch against a complete decision

Before accepting material, bring the evidence together: confirmed identity, traceable batch documentation, a suitable assay, controlled relevant impurities, representative sampling, and conformity with the applicable source requirements. Record any unresolved discrepancy and its disposition.

Physical properties may also need control for formulation use. Moisture, insoluble matter, particle characteristics, or other properties can affect processing and stability even when chemical purity is acceptable. Select these tests according to the intended formulation rather than assuming that a higher assay guarantees easier manufacture.

A practical release decision is straightforward: accept a batch when the evidence supports all agreed critical requirements; hold it when documentation or analytical discrepancies remain unresolved; reject it when a confirmed result fails an applicable acceptance criterion. Establish these rules before purchasing so commercial pressure does not redefine acceptable quality after delivery.

When comparing quotations, request the assay basis, impurity specification, method references, and manufacturing-source information alongside the CoA. Those details make a purity claim assessable and allow price comparisons between materials that actually meet the same requirements.